The stock price of the two most prominent players in the diabetes and obesity care market, Novo Nordisk NVO and Eli Lilly LLY ...

A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including ...

Tanya says she had always been fit and healthy as a size 10 youngster, but piled on weight after marriage and children ...

Tori Spelling's alarming weight loss has sparked growing concerns, with many fearing her drastic transformation could be ...

A study by the Department of Veterans Affairs says that drugs like Ozempic can do plenty more than just help with weight loss ...

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...

A comprehensive new study supports evidence of the myriad health benefits of GLP-1 medications like Ozempic and Mounjaro — ...

A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including dementia and cardiovascular diseases, although experts warned against seeing ...

Tirzepatide, the main ingredient in Mounjaro and Zepbound, is no longer in shortage, according to the U.S. Food and Drug Administration. Compounded copycat drugs containing tirzepatide ...

There have been few studies that have been able to take a comprehensive look at how these medications, which include Ozempic, ...

We recently compiled a list of the 9 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Eli ...

Eli Lilly unexpectedly lowered its full-year 2024 guidance. The miss appears to stem from a lack of the typical December ...